Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program

PURPOSE: The aim of this study was to confirm the efficacy and safety of regorafenib for advanced gastrointestinal stromal tumors (GISTs) reported in the GRID phase III trial in Korean patients. MATERIALS AND METHODS: Fifty-seven Korean patientswith advanced GISTwho experienced both imatinib and sun...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res Treat
Autors principals: Son, Myoung Kyun, Ryu, Min-Hee, Park, Joon Oh, Im, Seock-Ah, Kim, Tae-Yong, Lee, Su Jin, Ryoo, Baek-Yeol, Park, Sook Ryun, Kang, Yoon-Koo
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398393/
https://ncbi.nlm.nih.gov/pubmed/27456941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars